NCCN Guidelines® insights cancer-associated venous thromboembolic disease, version 2.2018 featured updates to the NCCN guidelines

Academic Article


  • Venous thromboembolism (VTE) is common in patients with cancer and increases morbidity and mortality. VTE prevention and treatment are more complex in patients with cancer. The NCCN Guidelines for Cancer-Associated Venous Thromboembolic Disease outline strategies for treatment and prevention of VTE in adult patients diagnosed with cancer or in whom cancer is clinically suspected. These NCCN Guidelines Insights explain recent changes in anticoagulants recommended for the treatment of cancer-associated VTE.
  • Authors

    Digital Object Identifier (doi)

    Author List

  • Streiff MB; Holmstrom B; Angelini D; Ashrani A; Bockenstedt PL; Chesney C; Fanikos J; Fenninger RB; Fogerty AE; Gao S
  • Start Page

  • 1289
  • End Page

  • 1303
  • Volume

  • 16
  • Issue

  • 11